Cartesian Therapeutics Correlations

RNAC Stock

6.76 0.45 6.24%

The current 90-days correlation between Cartesian Therapeutics and Nautilus Biotechnology is 0.04 (i.e., Significant diversification). The correlation of Cartesian Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Cartesian Therapeutics Correlation With Market

Average diversification

The correlation between Cartesian Therapeutics and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cartesian Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Cartesian Stock

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Cartesian Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Cartesian Stock refer to our How to Trade Cartesian Stock guide.

Moving together with Cartesian Stock

0.73	HPQ	HP Inc	Pair Corr
0.82	HD	Home Depot	Pair Corr
0.66	MSFT	Microsoft	Pair Corr

Moving against Cartesian Stock

0.82	AMGN	Amgen Inc	Pair Corr
0.8	CSCO	Cisco Systems	Pair Corr
0.78	CAT	Caterpillar	Pair Corr
0.77	GILD	Gilead Sciences	Pair Corr
0.77	XOM	Exxon Mobil Corp Aggressive Push	Pair Corr
0.76	KO	Coca Cola	Pair Corr
0.73	AXP	American Express	Pair Corr
0.71	BAC	Bank of America	Pair Corr
0.7	FTV	Fortive Corp	Pair Corr
0.69	MRK	Merck Company	Pair Corr
0.64	IBM	International Business	Pair Corr
0.59	MMM	3M Company	Pair Corr
0.58	TRV	The Travelers Companies	Pair Corr
0.47	JPM	JPMorgan Chase	Pair Corr
0.45	MCD	McDonalds	Pair Corr

Related Correlations Analysis

	EPRX	IVA	NAUT	OBIO	MDWD	AARD	FENC	AVTX	NTHI	GNFT
EPRX		-0.23	0.43	0.27	0.19	0.22	-0.39	0.28	-0.29	0.69	EPRX
IVA	-0.23		-0.68	-0.62	-0.06	0.47	0.79	-0.39	0.31	-0.31	IVA
NAUT	0.43	-0.68		0.91	0.04	-0.49	-0.79	0.77	-0.72	0.65	NAUT
OBIO	0.27	-0.62	0.91		0.17	-0.54	-0.8	0.77	-0.61	0.58	OBIO
MDWD	0.19	-0.06	0.04	0.17		0.18	-0.26	0.34	0.0	0.3	MDWD
AARD	0.22	0.47	-0.49	-0.54	0.18		0.34	-0.26	0.47	0.18	AARD
FENC	-0.39	0.79	-0.79	-0.8	-0.26	0.34		-0.64	0.46	-0.64	FENC
AVTX	0.28	-0.39	0.77	0.77	0.34	-0.26	-0.64		-0.65	0.66	AVTX
NTHI	-0.29	0.31	-0.72	-0.61	0.0	0.47	0.46	-0.65		-0.49	NTHI
GNFT	0.69	-0.31	0.65	0.58	0.3	0.18	-0.64	0.66	-0.49		GNFT
	EPRX	IVA	NAUT	OBIO	MDWD	AARD	FENC	AVTX	NTHI	GNFT

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

OBIO	+ 0.91	NAUT
FENC	+ 0.79	IVA
AVTX	+ 0.77	NAUT
AVTX	+ 0.77	OBIO
GNFT	+ 0.69	EPRX
GNFT	+ 0.66	AVTX

High negative correlations

FENC	- 0.8	OBIO
FENC	- 0.79	NAUT
NTHI	- 0.72	NAUT
NAUT	- 0.68	IVA
NTHI	- 0.65	AVTX
GNFT	- 0.64	FENC

Risk-Adjusted Indicators

There is a big difference between Cartesian Stock performing well and Cartesian Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cartesian Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
EPRX	2.64	0.35	0.12	0.31	2.91	(3.07)	6.71	(3.94)	20.44
IVA	4.64	(0.25)	0.00	(0.02)	0.00	0.00	9.72	(11.54)	34.91
NAUT	5.91	1.52	0.22	1.11	5.53	(8.28)	16.32	(12.00)	53.15
OBIO	4.15	0.83	0.21	0.40	3.69	(5.07)	11.08	(5.98)	25.95
MDWD	1.64	0.01	0.00	0.08	1.94	(1.99)	4.69	(3.44)	11.61
AARD	4.43	(0.02)	0.02	0.05	4.91	(4.88)	9.35	(8.66)	36.39
FENC	2.30	(0.31)	0.00	(0.32)	0.00	0.00	5.43	(4.94)	17.84
AVTX	3.78	0.47	0.11	0.38	4.28	(4.12)	10.71	(6.81)	25.25
NTHI	5.63	(0.02)	0.03	0.05	7.24	(6.26)	12.62	(11.89)	41.97
GNFT	3.22	0.77	0.16	1.98	3.55	(3.88)	8.47	(7.71)	25.18

Cartesian Therapeutics Corporate Management

Emily English	SVP Manufacturing	Profile
Peter MD	Chief Officer	Profile
Milos MD	Chief Officer	Profile
June Seymour	Chief Officer	Profile
Blaine Davis	Chief Officer	Profile
Matthew JD	General Secretary	Profile
Metin MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC